Showing results (1-10 of 194) with videos related to
Sort By:
Pageof 20
Expert Opinion on Investigational Drugs|February 28, 2002
HIV-1 protease inhibitors in developmentStefano Rusconi, Simona La Seta CatamancioExpert Review of Clinical Pharmacology|January 14, 2014
Tipranavir: a novel protease inhibitor for HIV therapyStefano RusconiCurrent Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Alovudine MedivirStefano RusconiBlood|November 19, 2005
Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytesAttilio Bondanza, Veronica Valtolina, Zulma Magnani, et al.Expert Opinion on Investigational Drugs|December 13, 2006
Novel inhibitors of the early steps of the HIV-1 life cyclePaola Citterio, Stefano RusconiBlood|November 4, 2008
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytesShin Kaneko, Sara Mastaglio, Attilio Bondanza, et al.Expert Review of Clinical Pharmacology|June 16, 2020
The crosstalk between antiretrovirals pharmacology and HIV drug resistanceAndrea Giacomelli, Laura Pezzati, Stefano RusconiThe New Microbiologica|April 4, 2017
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspectiveStefano Rusconi, Simone Marcotullio, Antonella CingolaniExpert Review of Clinical Pharmacology|December 21, 2018
Clinical pharmacology in HIV cure research - what impact have we seen?Andrea Giacomelli, Sonia de Rose, Stefano RusconiThe Enzymes|November 14, 2025
HIV protease and its inhibitionStefano Rusconi, Niccolò Paoletti, Claudiu T SupuranPageof 20